| Date | Time | Source | Announcement |
|---|---|---|---|
| 29 Jan 2004 | 11:00 AM | Final Results - Part 2 of 2 | |
| 29 Jan 2004 | 11:00 AM | Final Results - Part 1 of 2 | |
| 29 Jan 2004 | 07:00 AM | Nexium NSAID | |
| 28 Jan 2004 | 09:00 AM | Notice of Results | |
| 23 Jan 2004 | 05:48 PM | Holding(s) in Company | |
| 22 Jan 2004 | 02:30 PM | Holding in Company | |
| 13 Jan 2004 | 07:00 AM | Seroquel | |
| 23 Dec 2003 | 03:15 PM | Exanta | |
| 23 Dec 2003 | 01:15 PM | Exanta | |
| 19 Dec 2003 | 07:00 AM | Transaction in Own Shares | |
| 18 Dec 2003 | 07:00 AM | Transaction in Own Shares | |
| 15 Dec 2003 | 07:00 AM | Transaction in Own Shares | |
| 12 Dec 2003 | 09:30 AM | Prilosec Appeal Result | |
| 12 Dec 2003 | 07:00 AM | Transaction in Own Shares | |
| 10 Dec 2003 | 07:00 AM | Transaction in Own Shares | |
| 09 Dec 2003 | 07:00 AM | Transaction in Own Shares | |
| 08 Dec 2003 | 07:01 AM | Exanta | |
| 08 Dec 2003 | 07:00 AM | Transaction in Own Shares | |
| 04 Dec 2003 | 07:00 AM | Transaction in Own Shares | |
| 02 Dec 2003 | 07:00 AM | Transaction in Own Shares | |
| 01 Dec 2003 | 07:00 AM | Purchase of Own Securities | |
| 28 Nov 2003 | 07:00 AM | Purchase of Own Securities | |
| 27 Nov 2003 | 07:00 AM | Purchase of Own Securities | |
| 26 Nov 2003 | 07:00 AM | Purchase of Own Securities | |
| 24 Nov 2003 | 07:00 AM | Purchase of Own Securities | |
| 21 Nov 2003 | 07:00 AM | Purchase of Own Securities | |
| 20 Nov 2003 | 04:00 PM | Director Shareholding | |
| 19 Nov 2003 | 07:00 AM | Purchase of Own Securities | |
| 18 Nov 2003 | 07:00 AM | Purchase of Own Securities | |
| 17 Nov 2003 | 08:30 AM | Symbicort Turbuhaler | |
| 14 Nov 2003 | 07:00 AM | Purchase of Own Securities | |
| 13 Nov 2003 | 04:23 PM | Director Shareholding | |
| 13 Nov 2003 | 07:00 AM | Purchase of Own Securities | |
| 11 Nov 2003 | 02:00 PM | Exanta | |
| 07 Nov 2003 | 07:00 AM | Purchase of Own Securities | |
| 05 Nov 2003 | 07:00 AM | Purchase of Own Securities | |
| 04 Nov 2003 | 07:00 AM | Purchase of Own Securities | |
| 31 Oct 2003 | 07:00 AM | Purchase of Own Securities | |
| 30 Oct 2003 | 01:00 PM | Seroquel Approvable Letter | |
| 30 Oct 2003 | 07:00 AM | Purchase of Own Securities | |
| 29 Oct 2003 | 04:53 PM | Director Shareholding | |
| 29 Oct 2003 | 07:00 AM | Purchase of Own Securities | |
| 27 Oct 2003 | 07:00 AM | Purchase of Own Securities | |
| 23 Oct 2003 | 11:00 AM | 3rd Quarter Results -Part 2/2 | |
| 23 Oct 2003 | 11:00 AM | 3rd Quarter Results -Part 1/2 | |
| 23 Oct 2003 | 09:33 AM | Correction to Notice | |
| 22 Oct 2003 | 09:00 AM | Notice of 3rd Quarter Results | |
| 16 Oct 2003 | 01:03 PM | Collaboration with Abgenix | |
| 13 Oct 2003 | 08:30 AM | Seroquel | |
| 02 Oct 2003 | 01:00 PM | Annual Business Review |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.